News

Blog posts

Cars on a busy road with skyscrapers on both sides.

How Far Are Rare Patients Going for Care?

By AllStripes Research
Read the results of our Distance to Care survey for patients with lysosomal storage disorders.
Text reads: COVID-19 and You; We asked you to tell us about COVID-19's impact on your healthcare experiences. 731 of you responded. Here's what we learned.

COVID-19 and the Rare Community

By AllStripes Research
Read the results of our COVID-19 healthcare impact survey.

AllStripes Is a Public Benefit Corporation

AllStripes officially reincorporated as a Public Benefit Corporation (PBC) in August 2021. A benefit corporation is a for-profit company that weighs social good in its business decision-making.
"Series B Funding" appears over the words "$50 million to transform rare disease research" with the AllStripes logo below.

AllStripes Raises $50 Million in Series B Funding to Transform Rare Disease Research

The AllStripes team is thrilled to announce we’ve raised $50 million in Series B financing to greatly expand our impact and continue building the leading research platform in rare disease.

AllStripes Expands Rare Disease Research Programs to United Kingdom

Rare patients and caregivers in the U.K. can now participate in AllStripes research toward new treatments.

AllStripes 2020 Year in Review

By Talea Miller
View highlights from our research programs, community and team in 2020.

AllStripes Partners With Cambridge Rare Disease Network for ‘RAREfest20’ Virtual Festival

By Taylor Kane
AllStripes’ co-founder Onno Faber is a featured speaker at the festival, a free virtual event open to anyone interested in rare disease.

It’s Official, RDMD Has a New Name: AllStripes

Today, we revealed our new look, logo and name to the world: RDMD is now AllStripes Research!

‘It Is Time for Patients to Gain More Power Over Their Health’

By Charlene Fernandez
The Children’s Tumor Foundation, an AllStripes partner, is on a mission to show the value of patients’ voices and inclusion in the decision-making process.

How Myositis Support and Understanding Association Adapts and Stays Nimble

By Charlene Fernandez
Myositis Support and Understanding Association provides patients and caregivers the platforms, programs and resources they need to thrive while living with a chronic and debilitating rare disease.

A Message to Our Community: AllStripes Raises $14 Million to Advance Drug Development for Rare Diseases

Today, the AllStripes team is thrilled to announce we’ve raised $14 million in Series A financing.
All blog posts